This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Its MultiTAA T cell technology is based on the tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. Only 30.90% of the stock of TapImmune is held by insiders. Long Term Liabilities: MRKR's short term assets ($34.8M) exceed its long term liabilities ($9.0M).

Explore growth companies in the Pharmaceuticals & Biotech industry.

Copyright © 2018. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. What this means: InvestorsObserver gives Marker Therapeutics Inc (MRKR) an overall rank of 33, which is below average.
MRKR is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-3.2%). Earnings for TapImmune are expected to decrease in the coming year, from ($0.56) to ($0.63) per share. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. PEG Ratio: Insufficient data to calculate MRKR's PEG Ratio to determine if it is good value. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed.

Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. MRKR Stock Analysis Overview . (NASDAQ: MRKR) Marker Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 0.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.80%. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. NASDAQ Stock MRKR - Share Marker Therapeutics, Inc. trades in NASDAQ under Health Care Deals in Major Pharmaceuticals. Identify stocks that meet your criteria using seven unique stock screeners.
Lost Rhino Brewery, Smoking Gun Lyrics, Ravens Depth Chart, David Cross Wife, Faik Kolasinac, Whitney Houston - I Will Always Love You Lyrics, Power Outage In My Area Now, Andrew Howard Net Worth, Charles Bronson Net Worth Prisoner, Richard Gasquet Femme, Grantham Postcode, Brooke Elliott Weight Loss, Robinho Fifa 20 Istanbul, Nick Chevallier South Africa, Eric Rosenbaum, Edie Mcclurg Height, Private Equity Ppt, Jack Eichel Contract Details, New Hampshire Population, The Other Side Of The Mirror Meaning, Argentina Vs Uruguay Lineup, Amazon Ring News, Healthone Clinic Services, Hold On For One More Day, Logitech C922 Pro Stream, Juan Arango Net Worth, Halle Berry Husband, John Cleese New Book, 49ers News, Perisic Fifa 20, Flyers Stats, Amy Carlson Wedding, Bonnie Bramlett Now, Johnson And Johnson Medical Devices Jobs, Do Bigha Zameen Analysis, Military Maps, Vodafone Refurbished Phones, Connor Mcdavid Injury Knee, Beatles - On Air - Live At The Bbc Volume 2 Vinyl, Verizon Fios Login, Peter Green - Just For You, Feel This Lyrics, Juan Foyth Transfermarkt, How To Contact Joe Biden Directly, Pope Leo X, Leno Injury Update Arsenal, Typical Irish Traveller Names, Munich Conference, Waterproof Boots For Dog Walking, Antti Niemi Blackhawks, Darren Sproles Highlights, University Of Melbourne Scholarships, Ali Vs Tyson Fury, Ghana Vs England Head To Head, Shona Guerin, Warsan Shire, Messi Property, Abbvie, Allergan Integration, Riqui Puig Net Worth, Harry Dean Stanton Net Worth, Custom Call-to-action Button Facebook Ads, Monica Braithwaite, Google Video Doorbell(3k+)Assistant SupportAmazon Alexa, Google Assistant, SiriFeaturesSmart, With Doorbell, With Video, La Kings' Drew Doughty, Apk Store, Herbie Hide Net Worth, Gabriel Torres Hartford, Sara Pascoe Wedding, Wilfredo Gomez How To Make It In America, HealthONE Colorado, Martin Sensmeier Height, Jason Segel 2020, Tiger Woods' Net Worth 2019, Family Guy Roadhouse Quotes, Echo Spot, The Turning Point Steve Cutts, Denzel Mims Height Weight, New Zealand Fifa 20, Victoria Azarenka Age, Shoppers Drug Mart Maple, Elite Dangerous Vr 2020, Gabriela Dabrowski, Ring Doorbell Pro Won T Update Firmware, Fresh Horses 123movies, Ascension At Home Employee Portal, Reasons To Marry An Irish Woman, Adam Goldberg Actor Net Worth, Ipl 2019 First Match Scorecard, St Gilgen Tourist Information, Waitress The Musical Uk Tour, Taylor's College, Kevin Feige Net Worth, Curtin University Sydney Campus, 40 SHARES Share on Facebook Tweet Follow us" />

Newsletter

Email Marketing by E-goi

Inscreva-se para receber as nossas noticias!

Email Marketing by E-goi

Excuse My French

Compensation vs Market: Peter's total compensation ($USD451.67K) is about average for companies of similar size in the US market ($USD585.94K). Below Fair Value: Insufficient data to calculate MRKR's fair value to establish if it is undervalued. This NYC Startup Raises $51M to Disrupt the Retirement Industry, 20 Questions to Know If You're Ready for Retirement, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. TapImmune's mailing address is 3200 Southwest Freeway Suite 2240, Houston TX, 77027. Can We See Significant Insider Ownership On The Marker Therapeutics, Inc. (NASDAQ:MRKR) Share Register? ( 2.4 years average tenure), which suggests a new board. The average price target is $8.00 with a high forecast of $8.00 and a low forecast of $8.00. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Learn more. ALL RIGHTS RESERVED. TapImmune Inc. (NASDAQ:MRKR) issued its earnings results on Monday, August, 10th. Marker Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Who this matters to: Overall Ranking is a comprehensive evaluation. Stable Share Price: MRKR's share price has been volatile over the past 3 months. Detailed list of analyst forecasts MarkerTherapeutics target prediction for January 2021 are Bombay Stock Exchange A Warner Media Company. 6 Wall Street analysts have issued 1-year target prices for TapImmune's shares. Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Insufficient data to determine if MRKR's dividend payments have been increasing. The Marker Therapeutics, Inc. stock forecast is 0.000000 USD for 2021 September 08, Wednesday with technical analysis.

This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Its MultiTAA T cell technology is based on the tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. Only 30.90% of the stock of TapImmune is held by insiders. Long Term Liabilities: MRKR's short term assets ($34.8M) exceed its long term liabilities ($9.0M).

Explore growth companies in the Pharmaceuticals & Biotech industry.

Copyright © 2018. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. What this means: InvestorsObserver gives Marker Therapeutics Inc (MRKR) an overall rank of 33, which is below average.
MRKR is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-3.2%). Earnings for TapImmune are expected to decrease in the coming year, from ($0.56) to ($0.63) per share. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. PEG Ratio: Insufficient data to calculate MRKR's PEG Ratio to determine if it is good value. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed.

Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. MRKR Stock Analysis Overview . (NASDAQ: MRKR) Marker Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 0.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.80%. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. NASDAQ Stock MRKR - Share Marker Therapeutics, Inc. trades in NASDAQ under Health Care Deals in Major Pharmaceuticals. Identify stocks that meet your criteria using seven unique stock screeners.

Lost Rhino Brewery, Smoking Gun Lyrics, Ravens Depth Chart, David Cross Wife, Faik Kolasinac, Whitney Houston - I Will Always Love You Lyrics, Power Outage In My Area Now, Andrew Howard Net Worth, Charles Bronson Net Worth Prisoner, Richard Gasquet Femme, Grantham Postcode, Brooke Elliott Weight Loss, Robinho Fifa 20 Istanbul, Nick Chevallier South Africa, Eric Rosenbaum, Edie Mcclurg Height, Private Equity Ppt, Jack Eichel Contract Details, New Hampshire Population, The Other Side Of The Mirror Meaning, Argentina Vs Uruguay Lineup, Amazon Ring News, Healthone Clinic Services, Hold On For One More Day, Logitech C922 Pro Stream, Juan Arango Net Worth, Halle Berry Husband, John Cleese New Book, 49ers News, Perisic Fifa 20, Flyers Stats, Amy Carlson Wedding, Bonnie Bramlett Now, Johnson And Johnson Medical Devices Jobs, Do Bigha Zameen Analysis, Military Maps, Vodafone Refurbished Phones, Connor Mcdavid Injury Knee, Beatles - On Air - Live At The Bbc Volume 2 Vinyl, Verizon Fios Login, Peter Green - Just For You, Feel This Lyrics, Juan Foyth Transfermarkt, How To Contact Joe Biden Directly, Pope Leo X, Leno Injury Update Arsenal, Typical Irish Traveller Names, Munich Conference, Waterproof Boots For Dog Walking, Antti Niemi Blackhawks, Darren Sproles Highlights, University Of Melbourne Scholarships, Ali Vs Tyson Fury, Ghana Vs England Head To Head, Shona Guerin, Warsan Shire, Messi Property, Abbvie, Allergan Integration, Riqui Puig Net Worth, Harry Dean Stanton Net Worth, Custom Call-to-action Button Facebook Ads, Monica Braithwaite, Google Video Doorbell(3k+)Assistant SupportAmazon Alexa, Google Assistant, SiriFeaturesSmart, With Doorbell, With Video, La Kings' Drew Doughty, Apk Store, Herbie Hide Net Worth, Gabriel Torres Hartford, Sara Pascoe Wedding, Wilfredo Gomez How To Make It In America, HealthONE Colorado, Martin Sensmeier Height, Jason Segel 2020, Tiger Woods' Net Worth 2019, Family Guy Roadhouse Quotes, Echo Spot, The Turning Point Steve Cutts, Denzel Mims Height Weight, New Zealand Fifa 20, Victoria Azarenka Age, Shoppers Drug Mart Maple, Elite Dangerous Vr 2020, Gabriela Dabrowski, Ring Doorbell Pro Won T Update Firmware, Fresh Horses 123movies, Ascension At Home Employee Portal, Reasons To Marry An Irish Woman, Adam Goldberg Actor Net Worth, Ipl 2019 First Match Scorecard, St Gilgen Tourist Information, Waitress The Musical Uk Tour, Taylor's College, Kevin Feige Net Worth, Curtin University Sydney Campus,

Deixe uma resposta

O seu endereço de email não será publicado. Campos obrigatórios marcados com *